ENDO 2025 Resource Hub  – 

Welcome to our resource hub for the Annual Meeting of the Endocrine Society (ENDO) 2025! This is a one-stop-shop for all your ENDO 2025 needs. We will be updating the resource hub daily during the conference, so check back in for the latest on this fantastic meeting.

  1. Conference Website
  2. Conference Registration
  3. Day-by-Day Conference Preview
  4. Conference Program

Day-of Conference Reports

  1. ENDO 2025: T1D Fellows Day
  2. ENDO 2025 Day #1 Highlights
  3. ENDO 2025 Day #2 Highlights
  4. ENDO 2025 Day #3 Highlights
  5. ENDO 2025 Day #4 Highlights

Diabetes Therapy Highlights

  1. Dr. Anders Carlson on the next frontier in cardio-renal-metabolic care for type 1 diabetes

  2. Updates on insulin treatment, from pediatrics to adults to innovation

  3. Dr. Desmond Schatz on current and future immunotherapies for T1D

  4. Dr. Melanie Haines reviews muscle preservation strategies during GLP-1 RA-induced weight loss in obesity

  5. Dr. Christian Roth on a novel MC4R/GLP-1 receptor co-agonist peptide and its promise for glycemic and weight reduction

  6. Real-world perspectives on the clinical use of verapamil in T1D from Dr. Tugce Akcan

  7. Hypercortisolism in difficult-to-manage T2D: Experts review SEISMIC, CATALYST trials, and real-world evidence of Korlym

  8. The liver alpha cell axis: Glucagon action in diabetes, obesity, and MASLD

  9. Novel obesity therapeutics show promise: Amplifier’s dual AMPK and mitochondrial activator ATX-304, Juvena’s JUV-112, and Syntis Bio’s PERMEATE platform

  10. Beyond lifestyle: A review of the advances in the pharmacological management of pediatric obesity

  11. SGLT-2 inhibitors in practice: Minimizing risk and maximizing benefit for people with T2D

  12. Tips for endocrinologists: MASLD and its clinical considerations in an endocrinology clinic

  13. Incretins as “silver bullets”: Prof. Jens Juul Holst reviews incretin physiology and clinical benefits

  14. Post-plenary perspectives: Redefining obesity, individualizing treatment, and GLP-1 RAs in practice

  15. Tirzepatide confers greater weight loss and cardiometabolic gains in women

  16. Obesity pharmacotherapies: Where we’ve been, where we are now, and where we’re going

Diabetes Technology Highlights

  1. A deep dive into CGM optimization in clinical practice for AID and MDI

  2. Exercise management in T1D: Dr. Dessi Zaharieva shares tips and resources

  3. Year-in-review of diabetes technology: Global data, early CGM/AID, ketone monitoring, and equity in access

  4. Dr. Rayhan Lal calls for equitable access to advanced diabetes technology, offers practical strategies for clinicians managing T1D using AID, and reviews open-source innovation

  5. AID systems improve glycemic management without increasing hypoglycemia in older adults with T1D versus sensor-augmented pump therapy

  6. Interpreting A1c and CGM data: Their strengths, pitfalls, and clinical pearls on complementary use

Big Picture Highlights

  1. How to offer pediatric obesity and T1D management without stigma
  2. Seizing the serpent: Spotting, sizing up, and subduing insulin resistance in T1D

  3. Dr. Alyson Myers discusses the impact of implicit bias and differential access on diabetes care

  4. JCEM publishes guidelines for managing pre-existing diabetes during pregnancy

  5. Dr. Lowell Schmeltz discusses T1D screening, monitoring, and clinical considerations with Tzield

  6. The intersection of food insecurity, obesity, and inequity: A geospatial analysis of food deserts in Texas

  7. Bonus: Bustling Exhibit Hall opens at ENDO 2025

  8. Dr. Fatima Cody Stanford spotlights 2025 Scientific Report on nutrition and Lancet Commission on obesity definition

  9. Understanding the pathogenesis of T1D: An Endocrine Society scientific statement

  10. Triglyceride-glucose index as a predictor of CKD progression in adults with T2D

  11. The year in obesity: An overview of where we are and where we are going

  12. Weight stigma in healthcare: Impact, consequences, and a call to action

  13. Dr. Jennifer Kelley reviews current screening guidelines and management of adolescent hypercholesterolemia

  14. Quality improvement for inpatient diabetes care: Seven steps to successful implementation
  15. Evolving obesity care: A comparative look at surgery vs. medications
  16. Obesity management across the lifespan: Reproductive, pediatric, and geriatric considerations
  17. Dr. Ellen Seely emphasizes gestational diabetes as a critical predictor of T2D and cardiovascular disease risk
  18. Dr. Lisa Beutler describes biology behind obesity, from incretins to AgRP neuron activity
  19. Unique challenges of youth-onset T2D and the need for earlier, targeted intervention
  20. Genetic architecture of youth-onset T2D and insights from the ProDiGY consortium
  21. Metabolic imprinting: The transgenerational impact of gestational diabetes on youth-onset T2D

 

Previous ENDO Coverage on CCKB

  1. ENDO 2024 Resource Hub
  2. ENDO 2023 Resource Hub
  3. ENDO 2022 Resource Hub
  4. ENDO 2021 Resource Hub
  5. ENDO 2020
  6. ENDO 2019 Full Report
ENDO 2025 Resource Hub -
Top